Prostate Cancer Trial Results
U.S. Cancer Screening Trial Shows No Early Mortality Benefit from Annual Prostate Cancer Screening
(Posted: 03/18/2009) - Six annual screenings for prostate cancer led to more diagnoses of the disease, but no fewer prostate cancer deaths, according to a major new report from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, a 17-year project of the NCI. The PLCO was designed to provide answers about the effectiveness of prostate cancer screening.
Radiation Plus Hormone Therapy for Locally Advanced Prostate Cancer Improves Survival
(Posted: 02/03/2009) - Clinical trial results published online December 15, 2009, in The Lancet, affirms earlier studies showing that adding radiation therapy to hormone therapy (HT) is more effective than HT alone for locally advanced prostate cancer.
Studies Make Case for Finasteride to Prevent Prostate Cancer
(Posted: 06/24/2008) - Three new analyses of data from a large prostate cancer prevention trial bolster the case for finasteride as a preventive agent against prostate cancer, according to an article published online May 18, 2008, by the journal Cancer Prevention Research.
Comorbidities May Limit Benefits of Combination Prostate Therapy
(Posted: 01/30/2008) - Men with localized prostate cancer who are also ill with other disorders may suffer more from the negative side effects of anticancer treatments such as androgen suppression therapy, according to the Jan. 23, 2008, Journal of the American Medical Association.
Finasteride Not Linked to High-Grade Prostate Cancers
(Posted: 09/12/2007) - Finasteride is unlikely to induce high-grade prostate cancers in men who take the drug to prevent the disease, according to two studies released online Sept. 11, 2007, by the Journal of the National Cancer Institute.
(Posted: 03/18/2009) - Six annual screenings for prostate cancer led to more diagnoses of the disease, but no fewer prostate cancer deaths, according to a major new report from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, a 17-year project of the NCI. The PLCO was designed to provide answers about the effectiveness of prostate cancer screening.
Radiation Plus Hormone Therapy for Locally Advanced Prostate Cancer Improves Survival
(Posted: 02/03/2009) - Clinical trial results published online December 15, 2009, in The Lancet, affirms earlier studies showing that adding radiation therapy to hormone therapy (HT) is more effective than HT alone for locally advanced prostate cancer.
Studies Make Case for Finasteride to Prevent Prostate Cancer
(Posted: 06/24/2008) - Three new analyses of data from a large prostate cancer prevention trial bolster the case for finasteride as a preventive agent against prostate cancer, according to an article published online May 18, 2008, by the journal Cancer Prevention Research.
Comorbidities May Limit Benefits of Combination Prostate Therapy
(Posted: 01/30/2008) - Men with localized prostate cancer who are also ill with other disorders may suffer more from the negative side effects of anticancer treatments such as androgen suppression therapy, according to the Jan. 23, 2008, Journal of the American Medical Association.
Finasteride Not Linked to High-Grade Prostate Cancers
(Posted: 09/12/2007) - Finasteride is unlikely to induce high-grade prostate cancers in men who take the drug to prevent the disease, according to two studies released online Sept. 11, 2007, by the Journal of the National Cancer Institute.
